Public trial registry of the CCC-Munich

Trial CELESTIAL XL184-309

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CELESTIAL XL184-309
World
Full title
:

A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs. Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- K76.9 Leberkrankheit, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Oliver Ebert Keine Organisationseinheit angegeben Magnifier